- American City Business Journals•2 days ago
Durham-based contract drug manufacturer Patheon (PTHN) has hit the public markets with a successful launch, and is now looking ahead to potential acquisitions. After an initial public offering price of $21, shares quickly jumped to $25. It will use the roughly $625 million raised through the IPO to pay down debt, but look to grow in the future.
Jones Lang LaSalle IncorporatedNYSE
After hours: 109.300.71 (0.65%) as of 6:00 PM EDT
|Bid||90.00 x 100|
|Ask||109.30 x 100|
|52wk Range||90.07 - 179.97|
|Day's Range||106.80 - 109.20|
|Avg Vol (3m)||557,893|
As of 4:02 PM EDT. Market closed.